These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 24121191)

  • 41. Development and application of site mapping methods for the design of glycosaminoglycans.
    Agostino M; Gandhi NS; Mancera RL
    Glycobiology; 2014 Sep; 24(9):840-51. PubMed ID: 24859723
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Microbial synthesis of glycosaminoglycans and their oligosaccharides.
    Liu K; Guo L; Chen X; Liu L; Gao C
    Trends Microbiol; 2023 Apr; 31(4):369-383. PubMed ID: 36517300
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Chikungunya Virus Strains from Each Genetic Clade Bind Sulfated Glycosaminoglycans as Attachment Factors.
    McAllister N; Liu Y; Silva LM; Lentscher AJ; Chai W; Wu N; Griswold KA; Raghunathan K; Vang L; Alexander J; Warfield KL; Diamond MS; Feizi T; Silva LA; Dermody TS
    J Virol; 2020 Nov; 94(24):. PubMed ID: 32999033
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Glycosaminoglycans interact selectively with chemokines and modulate receptor binding and cellular responses.
    Kuschert GS; Coulin F; Power CA; Proudfoot AE; Hubbard RE; Hoogewerf AJ; Wells TN
    Biochemistry; 1999 Sep; 38(39):12959-68. PubMed ID: 10504268
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Molecular interactions of the anticancer agent ellipticine with glycosaminoglycans by in silico analysis.
    Zsila F; Samsonov SA
    Carbohydr Res; 2018 Jun; 462():28-33. PubMed ID: 29655053
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Docking glycosaminoglycans to proteins: analysis of solvent inclusion.
    Samsonov SA; Teyra J; Pisabarro MT
    J Comput Aided Mol Des; 2011 May; 25(5):477-89. PubMed ID: 21597992
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Glycosaminoglycan-Protein Interactions and Their Roles in Human Disease.
    Shi D; Sheng A; Chi L
    Front Mol Biosci; 2021; 8():639666. PubMed ID: 33768117
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Structural Insight into Non-Enveloped Virus Binding to Glycosaminoglycan Receptors: A Review.
    Sorin MN; Kuhn J; Stasiak AC; Stehle T
    Viruses; 2021 Apr; 13(5):. PubMed ID: 33946963
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Solution NMR characterization of chemokine CXCL8/IL-8 monomer and dimer binding to glycosaminoglycans: structural plasticity mediates differential binding interactions.
    Joseph PR; Mosier PD; Desai UR; Rajarathnam K
    Biochem J; 2015 Nov; 472(1):121-33. PubMed ID: 26371375
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of interleukin-8 truncations on its interactions with glycosaminoglycans.
    Nordsieck K; Baumann L; Hintze V; Pisabarro MT; Schnabelrauch M; Beck-Sickinger AG; Samsonov SA
    Biopolymers; 2018 Aug; 109(10):e23103. PubMed ID: 29377072
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The conformation and structure of GAGs: recent progress and perspectives.
    Rudd TR; Skidmore MA; Guerrini M; Hricovini M; Powell AK; Siligardi G; Yates EA
    Curr Opin Struct Biol; 2010 Oct; 20(5):567-74. PubMed ID: 20833032
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interaction of poly(glycoamidoamine) DNA delivery vehicles with cell-surface glycosaminoglycans leads to polyplex internalization in a manner not solely dependent on charge.
    McLendon PM; Buckwalter DJ; Davis EM; Reineke TM
    Mol Pharm; 2010 Oct; 7(5):1757-68. PubMed ID: 20604555
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CXCL1/MGSA Is a Novel Glycosaminoglycan (GAG)-binding Chemokine: STRUCTURAL EVIDENCE FOR TWO DISTINCT NON-OVERLAPPING BINDING DOMAINS.
    Sepuru KM; Rajarathnam K
    J Biol Chem; 2016 Feb; 291(8):4247-55. PubMed ID: 26721883
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Supercharged fluorescent protein as a versatile probe for the detection of glycosaminoglycans in vitro and in vivo.
    Wang W; Han N; Li R; Han W; Zhang X; Li F
    Anal Chem; 2015 Sep; 87(18):9302-7. PubMed ID: 26287436
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Using glycosaminoglycan/chemokine interactions for the long-term delivery of 5P12-RANTES in HIV prevention.
    Wang NX; Sieg SF; Lederman MM; Offord RE; Hartley O; von Recum HA
    Mol Pharm; 2013 Oct; 10(10):3564-73. PubMed ID: 23859720
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Targeting Chemokine-Glycosaminoglycan Interactions to Inhibit Inflammation.
    Crijns H; Vanheule V; Proost P
    Front Immunol; 2020; 11():483. PubMed ID: 32296423
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Glycosaminoglycan and Proteoglycan-Based Biomaterials: Current Trends and Future Perspectives.
    Rnjak-Kovacina J; Tang F; Whitelock JM; Lord MS
    Adv Healthc Mater; 2018 Mar; 7(6):e1701042. PubMed ID: 29210510
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Molecular Dynamics Simulation-Based Prediction of Glycosaminoglycan Interactions with Drug Molecules.
    Maszota-Zieleniak M; Samsonov SA
    Methods Mol Biol; 2024; 2714():143-153. PubMed ID: 37676597
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A Dilemma in the Glycosaminoglycan-Based Therapy: Synthetic or Naturally Unique Molecules?
    Pomin VH
    Med Res Rev; 2015 Nov; 35(6):1195-219. PubMed ID: 26152885
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Chemically modified glycosaminoglycan derivatives as building blocks for biomaterial coatings and hydrogels.
    Schnabelrauch M; Schiller J; Möller S; Scharnweber D; Hintze V
    Biol Chem; 2021 Oct; 402(11):1385-1395. PubMed ID: 34008374
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.